KR830007840A - β-락탐 화합물의 제조방법 - Google Patents

β-락탐 화합물의 제조방법 Download PDF

Info

Publication number
KR830007840A
KR830007840A KR1019810003723A KR810003723A KR830007840A KR 830007840 A KR830007840 A KR 830007840A KR 1019810003723 A KR1019810003723 A KR 1019810003723A KR 810003723 A KR810003723 A KR 810003723A KR 830007840 A KR830007840 A KR 830007840A
Authority
KR
South Korea
Prior art keywords
preparing
lactam compound
culture
carried out
compound
Prior art date
Application number
KR1019810003723A
Other languages
English (en)
Other versions
KR850000577B1 (ko
Inventor
미쓰야스 오까베
다께오 요시오까
야스오 후까가와
로꾸로 오까모또
가게아끼 고오노
도모유끼 이시꾸라
Original Assignee
스즈끼 시즈오
산라꾸오샨 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55135829A external-priority patent/JPS5762280A/ja
Priority claimed from JP55144507A external-priority patent/JPS5770890A/ja
Priority claimed from JP55170864A external-priority patent/JPS5795987A/ja
Application filed by 스즈끼 시즈오, 산라꾸오샨 가부시끼 가이샤 filed Critical 스즈끼 시즈오
Publication of KR830007840A publication Critical patent/KR830007840A/ko
Application granted granted Critical
Publication of KR850000577B1 publication Critical patent/KR850000577B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P37/00Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

β-락탐 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 다음 구조식의 화합물(Ⅰ-a)을 생산할 수 있는 미생물을 영양 배지에서 배양하고, 배양액에서 구조식(Ⅰ-a)화합물을 회수한 후, 필요하면 구조식(Ⅰ-a)화합물을 그 염 또는 치환 또는 비치환의 벤질 에스테르로 전환시키는 공정을 포함하는 제1항의 화합물을 제조하는 방법.
    (상기식에서, R1은 수소원자, -OH 또는 -OSO3H기이다).
  2. 제1항의 방법에서, 미생물이 스트렙토마이세스 sp. OA-6129(FERM BP-11)인 방법.
  3. 제1항의 방법에서, 배양을 호기성 조건하에 행하는 방법.
  4. 제1항의 방법에서, 배양을 20∼40℃의 온도 및 pH 4∼9에서 행하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810003723A 1980-10-01 1981-10-02 β-락탐 화합물의 제조방법 KR850000577B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP135829/80 1980-10-01
JP55135829A JPS5762280A (en) 1980-10-01 1980-10-01 Novel antibiotic oa-6129a and its preparation
JP144507/80 1980-10-17
JP55144507A JPS5770890A (en) 1980-10-17 1980-10-17 Novel antibiotic oa-6129b and its preparation
JP170864/80 1980-12-05
JP55170864A JPS5795987A (en) 1980-12-05 1980-12-05 Novel antibiotic oa-6129c and its preparation

Publications (2)

Publication Number Publication Date
KR830007840A true KR830007840A (ko) 1983-11-07
KR850000577B1 KR850000577B1 (ko) 1985-04-29

Family

ID=27317159

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810003723A KR850000577B1 (ko) 1980-10-01 1981-10-02 β-락탐 화합물의 제조방법

Country Status (6)

Country Link
US (1) US4426390A (ko)
EP (1) EP0048999B1 (ko)
KR (1) KR850000577B1 (ko)
CA (1) CA1182413A (ko)
DE (1) DE3171598D1 (ko)
ES (1) ES505886A0 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068485B1 (en) * 1981-07-01 1987-11-11 Sanraku Incorporated Novel antibiotics and process for production thereof
JPS5857392A (ja) * 1981-10-02 1983-04-05 Sanraku Inc 新規な抗生物質oa−6129のリン酸エステル
KR840003255A (ko) * 1982-01-28 1984-08-20 스즈끼 시즈오 항생물질 oa-6129a,b1,b2의 유도체 및 그 제법
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
CH632508A5 (de) * 1975-11-21 1982-10-15 Merck & Co Inc Verfahren zur herstellung von neuen estern des n-acylierten thienamycins.
AU6377980A (en) * 1979-10-29 1981-05-07 Beecham Group Limited 1-azabicyclo(3,2,0)hept-2-ene derivatives

Also Published As

Publication number Publication date
EP0048999B1 (en) 1985-07-31
KR850000577B1 (ko) 1985-04-29
ES8302093A1 (es) 1983-01-01
CA1182413A (en) 1985-02-12
US4426390A (en) 1984-01-17
ES505886A0 (es) 1983-01-01
EP0048999A1 (en) 1982-04-07
DE3171598D1 (en) 1985-09-05

Similar Documents

Publication Publication Date Title
BG35900A3 (en) Method for preparing antibiotic c- 076
KR950701976A (ko) F0-1289 물질 및 그의 생산방법
KR840005483A (ko) A47934 항생물질의 제조방법
KR840003696A (ko) 2-케토-l-굴론산의 제조방법
KR860001120A (ko) 폴리사이클릭 에테르 항생물질의 제조방법
KR830007840A (ko) β-락탐 화합물의 제조방법
KR920008193A (ko) 카르바스틴의 제조방법
KR850001284A (ko) 키브델로스포렌지움 애리덤(kibdelosporangium aridum)쉬어리(shearer)젠.노브., 에스.피.노브.(gen. nov., sp. nov.)atcc 39323에 의해 생산되는 항생물질들
KR830007830A (ko) 엔듀라시딘 및 그를 위한 미생물의 제조방법
KR840004442A (ko) 란카시딘의 개량 제조방법
KR890008325A (ko) 아미노디옥시 만니톨의 제법
BG33589A3 (en) Method for glucoseisomeric enzime obtaining
KR880004080A (ko) 빙핵 형성 활성을 갖는 미생물의 생산
KR920004562A (ko) Phb-비함유 젤란 검 발효액
KR940011639A (ko) D-만델산의 제조 방법
KR830006432A (ko) 헤테로 폴리싸카라이드 s-119의 제법
KR850003732A (ko) 항생물질 a39079 인자 s-1의 제조방법
KR930004467A (ko) α-히드록시 이소부틸아미드의 제조방법
KR830010197A (ko) 나라신의 제조방법
IL88088A0 (en) Microbiological process for making uk-61,689 and microorganisms useful therefor
DE3584593D1 (de) Peroxidase und verfahren zu deren herstellung.
KR830000720A (ko) 신규의 항생물질 네플라노씬류의 제조방법
KR880001820A (ko) L-글루탐산을 제조하는 발효방법
JPS5521A (en) Production of coenzyme q10 through fermentation
KR870001313A (ko) 라브단 테르페노이드의 미생물적 하이드록실화 또는 산화방법